体外受精中控制性卵巢刺激的监测。
Monitoring of controlled ovarian stimulation in IVF.
机构信息
IVF Unit, Elisha Hospital, Haifa, Israel.
Department of Reproductive Medicine, Instituto Bernabeu, Alicante, Spain.
出版信息
J Assist Reprod Genet. 2024 Jul;41(7):1715-1717. doi: 10.1007/s10815-024-03182-x. Epub 2024 Jul 4.
Abstract
Since the inception of in vitro fertilization (IVF), monitoring of controlled ovarian stimulation (COS) has traditionally involved numerous appointments for ultrasound and laboratory testing to guide medication use and dosing, determine trigger timing, and allow for measures to reduce the risk of ovarian hyperstimulation syndrome (OHSS). Recent advances in the field of assisted reproductive technology (ART) have called into question the timing and frequency of COS monitoring appointments, as discussed in this commentary.
摘要
自从体外受精（IVF）诞生以来，控制性卵巢刺激（COS）的监测传统上需要进行多次超声和实验室检查，以指导药物使用和剂量、确定触发时机，并采取措施降低卵巢过度刺激综合征（OHSS）的风险。本文述评讨论了辅助生殖技术（ART）领域的最新进展对 COS 监测预约时间和频率提出的质疑。
相似文献
1
Monitoring of controlled ovarian stimulation in IVF.体外受精中控制性卵巢刺激的监测。
J Assist Reprod Genet. 2024 Jul;41(7):1715-1717. doi: 10.1007/s10815-024-03182-x. Epub 2024 Jul 4.
2
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).辅助生殖（体外受精和卵胞浆内单精子注射）中刺激周期的监测。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD005289. doi: 10.1002/14651858.CD005289.pub2.
3
Ovarian stimulation in ART - Unwinding pressing issues.辅助生殖技术中的卵巢刺激——解决紧迫问题
Minerva Ginecol. 2015 Apr;67(2):127-47. Epub 2015 Feb 10.
4
In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.多囊卵巢综合征患者未使用促性腺激素的体外成熟与超排卵体外受精的比较：一项非劣效性随机对照试验。
Hum Reprod. 2022 Jan 28;37(2):242-253. doi: 10.1093/humrep/deab243.
5
6
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.多囊卵巢综合征患者在体外受精或卵胞浆内单精子注射前和期间使用二甲双胍治疗。
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4.
7
[IVF in a modified natural cycle].[改良自然周期中的体外受精]
Ned Tijdschr Geneeskd. 2010;154(45):A2519.
8
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.促黄体激素释放激素 54 对高风险卵巢过度刺激综合征患者卵母细胞成熟的改善作用：一项 2 期随机对照试验。
Hum Reprod. 2017 Sep 1;32(9):1915-1924. doi: 10.1093/humrep/dex253.
9
Why more is less and less is more when it comes to ovarian stimulation.为何在卵巢刺激方面多即少、少即多。
J Assist Reprod Genet. 2015 Dec;32(12):1713-9. doi: 10.1007/s10815-015-0599-7. Epub 2015 Oct 19.
10
Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.kisspeptin-54在体外受精（IVF）治疗期间对卵巢过度刺激综合征（OHSS）高危女性触发卵母细胞成熟的疗效。
J Clin Endocrinol Metab. 2015 Sep;100(9):3322-31. doi: 10.1210/jc.2015-2332. Epub 2015 Jul 20.
引用本文的文献
1
High concentration of estrogen resulted by COH may affect the secretion of pro-angiogenic factors in uNK cells by downregulating the expression of IL-11 in decidual stromal cells.控制性卵巢刺激（COH）导致的高雌激素浓度可能通过下调蜕膜基质细胞中白细胞介素-11（IL-11）的表达来影响子宫自然杀伤（uNK）细胞中促血管生成因子的分泌。
J Assist Reprod Genet. 2024 Nov;41(11):3189-3200. doi: 10.1007/s10815-024-03241-3. Epub 2024 Sep 14.
本文引用的文献
1
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).采用卵巢储备标志物对接受体外受精加胞浆内单精子注射（IVF/ICSI）的女性进行个体化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2024 Jan 4;1(1):CD012693. doi: 10.1002/14651858.CD012693.pub3.
2
Random-start ovarian stimulation in an oocyte donation programme: a large, single-centre, experience.随机起始卵巢刺激在卵子捐赠计划中的应用：一项大型单中心经验。
Reprod Biomed Online. 2024 Jan;48(1):103572. doi: 10.1016/j.rbmo.2023.103572. Epub 2023 Oct 4.
3
Free your patients and yourself from day 2-3: start ovarian stimulation any time in freeze-all cycles.让患者和您自己从第 2-3 天中解脱出来：在所有冻融周期中，随时开始卵巢刺激。
Reprod Biomed Online. 2023 Oct;47(4):103305. doi: 10.1016/j.rbmo.2023.103305. Epub 2023 Jul 23.
4
Changing stimulation protocol on repeat conventional ovarian stimulation cycles does not lead to improved laboratory outcomes.在重复的常规卵巢刺激周期中改变刺激方案并不会导致实验室结果的改善。
Fertil Steril. 2021 Sep;116(3):757-765. doi: 10.1016/j.fertnstert.2021.04.030. Epub 2021 May 24.
5
Streamlining follicular monitoring during controlled ovarian stimulation: a data-driven approach to efficient IVF care in the new era of social distancing.简化控制性卵巢刺激期间的卵泡监测：在社交距离新时代高效进行 IVF 护理的一种数据驱动方法。
Hum Reprod. 2021 Jan 1;36(1):99-106. doi: 10.1093/humrep/deaa251.
6
The number of oocytes retrieved during IVF: a balance between efficacy and safety.体外受精中获取的卵母细胞数量：在疗效和安全性之间取得平衡。
Hum Reprod. 2018 Jan 1;33(1):58-64. doi: 10.1093/humrep/dex334.
7
Variation in antral follicle counts at different times in the menstrual cycle: does it matter?月经周期不同时间窦卵泡计数的变化：这重要吗？
Reprod Biomed Online. 2016 Aug;33(2):174-9. doi: 10.1016/j.rbmo.2016.04.012. Epub 2016 May 5.
8
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?体外受精/卵胞浆内单精子注射的传统卵巢刺激和单胚胎移植。在利用所有新鲜和冷冻胚胎后，我们需要多少个卵母细胞才能使累积活产率最大化？
Hum Reprod. 2016 Feb;31(2):370-6. doi: 10.1093/humrep/dev316. Epub 2016 Jan 2.
9
Reducing the Risk of OHSS by GnRH Agonist Triggering.通过 GnRH 激动剂触发降低 OHSS 风险。
J Clin Endocrinol Metab. 2015 Dec;100(12):4396-8. doi: 10.1210/jc.2015-3676. Epub 2015 Oct 29.
10
Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol.在 GnRH 拮抗剂方案中，接受重复使用戈那瑞林激动剂的患者的卵巢反应在周期间存在可变性。
Fertil Steril. 2015 Oct;104(4):884-890.e2. doi: 10.1016/j.fertnstert.2015.06.027. Epub 2015 Jul 15.
Zotero 插件